Hongkong Huangdaoyi Medicine Group Holdings Ltd in London, N14 5BP

Description

Data updated on: 01-11-2023

Hongkong Huangdaoyi Medicine Group Holdings Ltd could be gotten hold of in Suite 108 Chase Business Centre, 39-41 Chase Side in London. Its area code is N14 5BP. Hongkong Huangdaoyi Medicine Group Holdings has been present on the market for eight years. Its Companies House Reg No. is 09977826. The company's SIC and NACE codes are 99999 and has the NACE code: Dormant Company. 31st January 2023 is the last time account status updates were filed.

Presently, the limited company is directed by just one managing director: Yongquan P., who was appointed in August 2016. Since 2016 Weijie P., had been functioning as a director for this specific limited company up until the resignation in 2016.

Yuanzong C. is the individual who controls this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2017-01-31	2018-01-31	2019-01-31	2020-01-31	2021-01-31	2022-01-31	2023-01-31	2024-01-31
Currency
Net Worth	500 000	500 000

Balance Sheet
Net Assets Liabilities		500 000	500 000	500 000	500 000	500 000	500 000	500 000
Net Assets Liabilities Including Pension Asset Liability	500 000	500 000

Capital & Reserves
Shareholder Funds	500 000	500 000

Other Financial Data
Called Up Share Capital Not Paid Not Expressed As Current Asset	500 000	500 000	500 000	500 000	500 000	500 000	500 000	500 000
Number Shares Allotted	500 000	500 000	500 000	500 000	500 000	500 000	500 000	500 000
Par Value Share	1	1	1	1	1	1	1	1
Share Capital Allotted Called Up Paid	500 000	500 000

Company staff

Yongquan P.

Role: Director

Appointed: 17 August 2016

Latest update: 13 March 2024

People with significant control

Yuanzong C.

Notified on 6 June 2022

Nature of control:

over 3/4 of shares

Weijie P.

Notified on 14 March 2018

Ceased on 6 June 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Yongquan P.

Notified on 17 August 2016

Ceased on 14 March 2018

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

substantial control or influence

Accounts Documents

Account next due date	31 October 2024
Account last made up date	31 January 2023
Confirmation statement next due date	15 February 2024
Confirmation statement last made up date	01 February 2023

Annual Accounts 31 January 2017
Start Date For Period Covered By Report	2016-01-29
End Date For Period Covered By Report	2017-01-31
Date Approval Accounts	31 January 2017
Annual Accounts 31 January 2018
Start Date For Period Covered By Report	2017-02-01
End Date For Period Covered By Report	2018-01-31
Date Approval Accounts	31 January 2018
Annual Accounts
Start Date For Period Covered By Report	2018-02-01
End Date For Period Covered By Report	2019-01-31
Annual Accounts
Start Date For Period Covered By Report	2019-02-01
End Date For Period Covered By Report	2020-01-31
Annual Accounts
Start Date For Period Covered By Report	2020-02-01
End Date For Period Covered By Report	2021-01-31
Annual Accounts
Start Date For Period Covered By Report	2021-02-01
End Date For Period Covered By Report	2022-01-31
Annual Accounts
Start Date For Period Covered By Report	2022-02-01
End Date For Period Covered By Report	2023-01-31
Annual Accounts
Start Date For Period Covered By Report	2023-02-01
End Date For Period Covered By Report	2024-01-31

Hongkong Huangdaoyi Medicine Group Holdings Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Yongquan P.

Uk Secretarial Services Limited

Weijie P.

People with significant control

Yuanzong C.

Weijie P.

Yongquan P.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies